Venture CapitalRIA · CRD 288280Exempt Reporting AdviserPrivate Fund Adviser

Updated:

Pitango Venture Capital

Pitango is Israel's largest and longest-standing venture capital fund. It invests in visionary founders and helps them build successful global companies, with...

Pitango Venture Capital logo

Pitango Venture Capital

Pitango is Israel's largest and longest-standing venture capital fund. It invests in visionary founders and helps them build successful global companies, with roots in Israel and global reach. It backs companies from seed to late growth through three dedicated funds: Pitango First, Pitango Growth, and Pitango HealthTech. The firm has backed 300+ companies, invested $3B+, and recorded 100+ exits across 13 funds.

General information

Firm type

Venture Capital

Year founded

1993

Location

Region

Middle East

Country

Israel

City

Tel Aviv

Corporate office

Herzliya, Israel

Principals

Nechemia (Chemi) J. Peres

Managing Partner & Co-Founder

Rami Kalish

Managing Partner & Co-Founder

Eyal Niv

Managing Partner | First

Aaron Mankovski

Managing Partner | Growth

Isaac Hillel

Managing Partner | Growth

Ayal Itzkovitz

Managing Partner | First

Ittai Harel

Managing Partner | HealthTech

Hila Karah

Managing Partner | HealthTech

Sector focus

AI/MLCybersecurityEnterprise SoftwareDigital HealthFinTechMobility & TransportationCloud InfrastructureAgriTech & FoodTechHealthcare ServicesMedical Devices

Frequently asked questions

How is Pitango structured across different investment stages?

Pitango operates three dedicated funds: Pitango First for seed and early-stage, Pitango Growth for venture and late-stage, and Pitango HealthTech for seed through growth in health-related sectors. Each fund is run by a focused managing partner team but shares the firm's centralized operational, legal, and marketing resources. This structure aims to provide continuity for portfolio companies as they mature without forcing founder turnover in investor relationships.

Who runs investment decisions at Pitango?

Investment decisions are handled by an eight-person managing partner group. Nechemia (Chemi) J. Peres and Rami Kalish are Co-Founders and Managing Partners. Eyal Niv and Ayal Itzkovitz lead the First fund; Aaron Mankovski and Isaac Hillel lead Growth; and Ittai Harel and Hila Karah lead HealthTech. This distributed leadership structure places individual fund decision-making with domain-dedicated partners.

How does Pitango source proprietary deal flow?

Pitango attributes its deal flow to 30 years of accumulated network effects within Israeli tech, including relationships with repeat entrepreneurs, venture partners, and strategic limited partners. The firm highlights specific venture partners—including Pascal Cagni (former Apple executive) and Amir Faintuch (former GlobalFoundries executive)—who expand sourcing into global operating ecosystems. The centralized platform also funnels early-stage deal flow into the First fund, which can later feed the Growth fund.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Tel Aviv Venture Capital profiles